CV Sciences, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Net Income (Loss) Per Share

Net Income (Loss) Per Share

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Net Income (Loss) Per Share

11.

NET INCOME (LOSS) PER SHARE

The Company computes basic net income (loss) per share using the weighted-average number of common shares outstanding during the year. Diluted net income (loss) per share is calculated by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares plus potential common shares. The Company's stock options, including those with performance conditions, are included in the calculation of diluted net income (loss) per share using the treasury stock method when their effect is dilutive. Potential common shares are excluded from the calculation of diluted net income (loss) per share when their effect is anti-dilutive.

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):


	For the years ended December 31,
	2024			2023
Numerator:
Net income (loss)	$	(2,394	)	$	3,102
Denominator for basic and diluted net income (loss) per share:
Weighted average common shares outstanding for basic		175,585			153,954
Dilutive potential common stock outstanding:
Stock options		—			1
Weighted average common shares outstanding for diluted		175,585			153,955
Basic net income (loss) per share	$	(0.01	)	$	0.02
Diluted net income (loss) per share	$	(0.01	)	$	0.02

The following common stock equivalents were not included in the calculation of net income (loss) per diluted share because their effect were anti-dilutive (in thousands):


	For the years ended December 31,
	2024		2023
Stock options		26,823		20,185
Performance stock options		6,750		11,000
Warrants		10,750		10,750
Total		44,323		41,935